tradingkey.logo

Moderna climbs on $1.9 billion 2025 sales forecast

ReutersJan 12, 2026 12:28 PM

Shares of vaccine maker Moderna MRNA.O rise 1.3% to $34.73 premarket

Company expects $1.9  billion in sales for 2025, which is near the upper end of its previously projected $1.6  billion to $2 billion range

MRNA cuts $200 million from 2025 operating expense forecast

Company is scheduled to report fourth-quarter and full 2025 results on February 13

Shares down 29.8% in 2025

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI